June 21 (Reuters) - Aziyo Biologics Inc AZYO.O :
* AZIYO BIOLOGICS APPOINTS DR. C. RANDAL MILLS AS INTERIM PRESIDENT AND CEO
* AZIYO BIOLOGICS INC - RONALD LLOYD WILL STEP DOWN FROM THESE POSITIONS BUT
WILL
REMAIN WITH COMPANY THROUGH END OF Q3 TO ASSIST WITH TRANSITION
* AZIYO BIOLOGICS INC - AZIYO CO-FOUNDER KEVIN RAKIN HAS ALSO ASSUMED ROLE
OF
EXECUTIVE CHAIRMAN
* AZIYO BIOLOGICS INC - COMPANY REAFFIRMS ITS PREVIOUSLY PROVIDED GUIDANCE
THAT
TOTAL NET SALES FOR FULL YEAR 2022 WILL RANGE BETWEEN OF $47 TO $50 MILLION
Source text for Eikon: ID:nGNX5Htvp3
Further company coverage: AZYO.O
((Reuters.Briefs@thomsonreuters.com;))